SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-327131
Filing Date
2021-11-12
Accepted
2021-11-12 06:13:48
Documents
14
Period of Report
2021-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d260057d8k.htm   iXBRL 8-K 24941
2 EX-99.1 d260057dex991.htm EX-99.1 42088
6 GRAPHIC g260057g66a38.jpg GRAPHIC 2778
  Complete submission text file 0001193125-21-327131.txt   204000

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20211111.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20211111_lab.xml EX-101.LAB 18889
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20211111_pre.xml EX-101.PRE 11855
7 EXTRACTED XBRL INSTANCE DOCUMENT d260057d8k_htm.xml XML 3470
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 211399055
SIC: 2834 Pharmaceutical Preparations